Literature DB >> 20857323

Osteoclastic cell behaviors affected by the α-tricalcium phosphate based bone cements.

Sun-Ae Oh1, Gil-Su Lee, Jeong-Hui Park, Hae-Won Kim.   

Abstract

Calcium phosphate cements (CPCs) have recently gained great interest as injectable bone substitutes for use in dentistry and orthopedics. α-tricalcium phosphate (α-TCP) is a popularly used precursor powder for CPCs. When mixed with appropriate content of liquid and kept under aqueous conditions, α-TCP dissolves to form a calcium-deficient hydroxyapatite and then hardens to cement. In this study, α-TCP based cement (CP) and its composite cement with chitosan (Ch-CP) were prepared and the osteoclastic responses to the cements and their elution products were evaluated. Preliminary evaluation of the cements revealed that the CP and Ch-CP hardened within ~10 min at an appropriate powder-to-liquid ratio (PL) of 3.0. In addition, CP and Ch-CP were transformed into an apatite phase following immersion in a saline solution. Moreover, the osteoblastic cells were viable on the cements for up to 10 days. Mouse-derived bone marrow cells were isolated and activated with osteoclastic differentiation medium, and the effects of the CP and Ch-CP substrates and their ionic eluants on the osteoclastic activity were investigated. Osteoclastic cells were viable for up to 14 days on both types of cements, maintaining a higher cell growth level than the control culture dish. Multi-nucleated osteoclastic cells that were tartrate-resistant acid phosphatase (TRAP)-positive were clearly observed when cultured on the cement substrates as well as treated with the cement eluants. The TRAP activity was found to be significantly higher in cells influenced by the cement substrates and their eluants with respect to the control culture dish (Ch-CP > CP ≫ control). Overall, the osteoclastic differentiation was highly stimulated by the α-TCP based experimental cements in terms of both the substrate interaction and their elution products.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857323     DOI: 10.1007/s10856-010-4152-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  17 in total

Review 1.  Chitosan chemistry and pharmaceutical perspectives.

Authors:  M N V Ravi Kumar; R A A Muzzarelli; C Muzzarelli; H Sashiwa; A J Domb
Journal:  Chem Rev       Date:  2004-12       Impact factor: 60.622

2.  Kinetic study of the setting reaction of a calcium phosphate bone cement.

Authors:  E Fernández; M P Ginebra; M G Boltong; F C Driessens; J Ginebra; E A De Maeyer; R M Verbeeck; J A Planell
Journal:  J Biomed Mater Res       Date:  1996-11

3.  Addition of cohesion promotors to calcium phosphate cements.

Authors:  I Khairoun; F C Driessens; M G Boltong; J A Planell; R Wenz
Journal:  Biomaterials       Date:  1999-02       Impact factor: 12.479

4.  Polymeric calcium phosphate cements: analysis of reaction products and properties.

Authors:  K Miyazaki; T Horibe; J M Antonucci; S Takagi; L C Chow
Journal:  Dent Mater       Date:  1993-01       Impact factor: 5.304

5.  In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate.

Authors:  F Monchau; A Lefèvre; M Descamps; A Belquin-myrdycz; P Laffargue; H F Hildebrand
Journal:  Biomol Eng       Date:  2002-08

6.  Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold.

Authors:  Jennifer L Moreau; Hockin H K Xu
Journal:  Biomaterials       Date:  2009-02-01       Impact factor: 12.479

7.  alpha-Tricalcium phosphate hydrolysis to hydroxyapatite at and near physiological temperature.

Authors:  C Durucan; P W Brown
Journal:  J Mater Sci Mater Med       Date:  2000-06       Impact factor: 3.896

8.  Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering.

Authors:  Hockin H K Xu; Janet B Quinn; Shozo Takagi; Laurence C Chow
Journal:  Biomaterials       Date:  2004-03       Impact factor: 12.479

9.  Resorbability of bone substitute biomaterials by human osteoclasts.

Authors:  Arndt F Schilling; Wolfgang Linhart; Sandra Filke; Matthias Gebauer; Thorsten Schinke; Johannes M Rueger; Michael Amling
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

10.  Basic properties of calcium phosphate cement containing atelocollagen in its liquid or powder phases.

Authors:  Y Miyamoto; K Ishikawa; M Takechi; T Toh; T Yuasa; M Nagayama; K Suzuki
Journal:  Biomaterials       Date:  1998 Apr-May       Impact factor: 12.479

View more
  5 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

2.  Alginate combined calcium phosphate cements: mechanical properties and in vitro rat bone marrow stromal cell responses.

Authors:  Gil-Su Lee; Jeong-Hui Park; Jong-Eun Won; Ueon Sang Shin; Hae-Won Kim
Journal:  J Mater Sci Mater Med       Date:  2011-04-02       Impact factor: 3.896

3.  Polymeric additives to enhance the functional properties of calcium phosphate cements.

Authors:  Roman A Perez; Hae-Won Kim; Maria-Pau Ginebra
Journal:  J Tissue Eng       Date:  2012-03-20       Impact factor: 7.813

4.  Preparation of in situ hardening composite microcarriers: calcium phosphate cement combined with alginate for bone regeneration.

Authors:  Jung-Hui Park; Eun-Jung Lee; Jonathan C Knowles; Hae-Won Kim
Journal:  J Biomater Appl       Date:  2013-07-08       Impact factor: 2.646

5.  A bone replacement-type calcium phosphate cement that becomes more porous in vivo by incorporating a degradable polymer.

Authors:  Akiyoshi Shimatani; Hiromitsu Toyoda; Kumi Orita; Yuta Ibara; Yoshiyuki Yokogawa; Hiroaki Nakamura
Journal:  J Mater Sci Mater Med       Date:  2021-06-22       Impact factor: 3.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.